Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Merck & Co., Inc.
Report date December 31, 2011 · Filed January 04, 2012
Section 16 reporting ended · disclosed 2012-01-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 70,990 |
Reported balance
After 2011-12-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2011-12-31 · Tax withholding · Disposed 8,969 · Balance 70,990 F1: Withheld shares related to the 12/31/11 vesting of stock units previously granted to the reporting person on March 30, 2009. F2: Holdings include dividends earned since November 3, 2009. |
| Common Stock - 401(k) PlanSEC Table I · non-derivative | IndirectBy 401(k) | 4,638.645 |
Reported balance
Holding disclosure · report date 2011-12-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4,638.645 F3: Includes shares acquired and dividends earned through December 31, 2011 in the Schering-Plough Employees' Savings Plan, a 401(k) Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Withheld shares related to the 12/31/11 vesting of stock units previously granted to the reporting person on March 30, 2009.
F2: Holdings include dividends earned since November 3, 2009.
F3: Includes shares acquired and dividends earned through December 31, 2011 in the Schering-Plough Employees' Savings Plan, a 401(k) Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2011 Filed Jan 4, 2012 21:24 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 8,969 | $37.70 | $338,131.30 |
DisclosureSEC source: 0001225208-12-000516 · doc4.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · Exe Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,990 F1 · shares: Withheld shares related to the 12/31/11 vesting of stock units previously granted to the reporting person on March 30, 2009. F2 · balance_after: Holdings include dividends earned since November 3, 2009. Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (right to buy) · Derivative | 63,881 | $0.00 Strike: $19.95 | $0.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · derivative · entry 29 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 63,881 shares Expires 2014-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 15,800 | $37.26 | $588,708.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 27 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,167 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 9,600 | $37.19 | $356,976.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 26 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,967 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 9,200 | $37.17 | $341,964.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 25 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,567 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 8,524 | $37.19 | $317,007.56 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 24 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,767 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 4,900 | $37.25 | $182,525.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 23 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,291 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 3,335 | $37.18 | $123,995.30 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 22 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,191 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 1,900 | $37.14 | $70,566.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 21 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,526 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 1,600 | $37.21 | $59,536.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 20 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,426 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 1,400 | $37.23 | $52,122.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 19 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,026 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 1,388 | $37.22 | $51,661.36 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 18 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,426 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 1,170 | $37.20 | $43,524.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 17 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,814 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 700 | $37.16 | $26,012.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 16 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,984 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 600 | $37.19 | $22,314.78 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 15 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,684 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 500 | $37.14 | $18,567.50 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 14 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,284 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 500 | $37.17 | $18,585.50 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 13 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,784 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 500 | $37.18 | $18,590.50 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 12 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,284 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 500 | $37.21 | $18,605.65 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 11 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,784 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 300 | $37.15 | $11,145.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 10 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,284 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 300 | $37.25 | $11,173.50 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 9 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,584 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 200 | $37.15 | $7,429.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 8 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,884 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 200 | $37.22 | $7,443.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 7 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,084 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 200 | $37.24 | $7,447.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 6 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,284 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 200 | $37.24 | $7,448.00 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 5 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,484 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 164 | $37.16 | $6,093.42 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 4 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,684 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 100 | $37.14 | $3,713.75 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 3 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,848 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 100 | $37.23 | $3,722.50 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,948 Read SEC document |
| May 18, 2011 Filed May 19, 2011 13:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 63,881 | $19.95 | $1,274,425.95 |
DisclosureSEC source: 0001225208-11-014791 · doc4.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 74,627 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013367 · doc4.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,627 Underlying: Common Stock · 74,627 shares Expires 2021-05-03 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 5,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013367 · doc4.xml · derivative · entry 3 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,470 Underlying: Common Stock · 5,470 shares Expires 2014-05-04 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| December 31, 2010 Filed Jan 4, 2011 20:47 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 10,204 | $36.04 | $367,752.16 |
DisclosureSEC source: 0001225208-11-000553 · doc4.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,167 F1 · shares: Withheld shares relate to the December 31, 2010, vesting of stock units previously granted to the reporting person on February 28, 2008. Read SEC document |
| May 07, 2010 Filed May 11, 2010 21:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 48,019 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012651 · doc4.xml · derivative · entry 4 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,019 Underlying: Common Stock · 48,019 shares Expires 2020-05-06 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 21:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 5,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012651 · doc4.xml · derivative · entry 3 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,972 Underlying: Common Stock · 5,972 shares Expires 2013-05-07 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| March 01, 2010 Filed Mar 1, 2010 21:38 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | Exercise / conversionEmployee Stock Option 2003/02/24 (right to buy) · Derivative | 22,449 | $0.00 Strike: $19.56 | $0.00 |
DisclosureSEC source: 0001209191-10-012998 · doc4.xml · derivative · entry 10 KOHAN RAUL E · CIK 0001238302 · ExecVP&PresAnimalHlth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,449 shares Expires 2013-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2010 Filed Mar 1, 2010 21:38 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | Exercise / conversionEmployee Stock Option 2003/02/24 (right to buy) · Derivative | 4,484 | $0.00 Strike: $19.56 | $0.00 |
DisclosureSEC source: 0001209191-10-012998 · doc4.xml · derivative · entry 9 KOHAN RAUL E · CIK 0001238302 · ExecVP&PresAnimalHlth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,484 shares Expires 2013-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2010 Filed Mar 1, 2010 21:38 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | SaleCommon Stock | 22,449 | $37.36 | $838,694.64 |
DisclosureSEC source: 0001209191-10-012998 · doc4.xml · nonDerivative · entry 6 KOHAN RAUL E · CIK 0001238302 · ExecVP&PresAnimalHlth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,266 Read SEC document |
| March 01, 2010 Filed Mar 1, 2010 21:38 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | Exercise / conversionCommon Stock | 22,449 | $19.56 | $439,102.44 |
DisclosureSEC source: 0001209191-10-012998 · doc4.xml · nonDerivative · entry 5 KOHAN RAUL E · CIK 0001238302 · ExecVP&PresAnimalHlth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2010 Filed Mar 1, 2010 21:38 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | SaleCommon Stock | 4,484 | $37.36 | $167,522.24 |
DisclosureSEC source: 0001209191-10-012998 · doc4.xml · nonDerivative · entry 4 KOHAN RAUL E · CIK 0001238302 · ExecVP&PresAnimalHlth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,266 Read SEC document |
| March 01, 2010 Filed Mar 1, 2010 21:38 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | Exercise / conversionCommon Stock | 4,484 | $19.56 | $87,707.04 |
DisclosureSEC source: 0001209191-10-012998 · doc4.xml · nonDerivative · entry 3 KOHAN RAUL E · CIK 0001238302 · ExecVP&PresAnimalHlth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2010 Filed Mar 1, 2010 21:38 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | Exercise / conversionEmployee Stock Option 2003/02/24 (right to buy) · Derivative | 27,000 | $0.00 Strike: $19.56 | $0.00 |
DisclosureSEC source: 0001209191-10-012998 · doc4.xml · derivative · entry 8 KOHAN RAUL E · CIK 0001238302 · ExecVP&PresAnimalHlth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,484 Underlying: Common Stock · 27,000 shares Expires 2013-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2010 Filed Mar 1, 2010 21:38 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | SaleCommon Stock | 27,000 | $37.00 | $999,000.00 |
DisclosureSEC source: 0001209191-10-012998 · doc4.xml · nonDerivative · entry 2 KOHAN RAUL E · CIK 0001238302 · ExecVP&PresAnimalHlth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,266 Read SEC document |
| February 26, 2010 Filed Mar 1, 2010 21:38 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | Exercise / conversionCommon Stock | 27,000 | $19.56 | $528,120.00 |
DisclosureSEC source: 0001209191-10-012998 · doc4.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · ExecVP&PresAnimalHlth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2010 Filed Feb 22, 2010 22:24 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 21,339 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-005225 · doc4.xml · derivative · entry 1 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,339 Underlying: Common Stock · 21,339 shares Expires 2013-02-19 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| November 19, 2009 Filed Nov 23, 2009 22:35 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 20,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-022760 · doc4.xml · nonDerivative · entry 1 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,182 F1 · shares: The acquisition of the shares was subject to the achievement of performance goals approved by the Compensation Committee of the Issuer. The shares will become payable on December 31, 2011 provided that the reporting person remains continuously employed by the Issuer through that date, or, if sooner, upon the reporting person's involuntary termination of employment other than for cause. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 5,192 | $0.00 Strike: $22.91 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · derivative · entry 15 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,008 Underlying: Common Stock · 5,192 shares Expires 2016-04-30 F18 · derivative.exercise_price: The option price for the grant expiring 4/30/16 will convert from $22.91 to $25.11. F7 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F6 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 4,999 | $0.00 Strike: $18.85 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · derivative · entry 14 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,001 Underlying: Common Stock · 4,999 shares Expires 2015-04-30 F17 · derivative.exercise_price: The option price for the grant expiring 4/30/15 will convert from $18.85 to $20.66. F7 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F6 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 8,770 | $0.00 Strike: $31.57 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · derivative · entry 13 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,230 Underlying: Common Stock · 8,770 shares Expires 2014-04-30 F16 · derivative.exercise_price: The option price for the grant expiring 4/30/14 will convert from $31.57 to $34.60. F7 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F6 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 8,770 | $0.00 Strike: $19.23 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · derivative · entry 12 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,230 Underlying: Common Stock · 8,770 shares Expires 2013-05-18 F15 · derivative.exercise_price: The option price for the grant expiring 5/18/13 will convert from $19.23 to $21.08. F7 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F6 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 9, 2009 17:36 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 8,770 | $0.00 Strike: $20.70 | $0.00 |
DisclosureSEC source: 0001225208-09-021935 · doc4.xml · derivative · entry 11 KOHAN RAUL E · CIK 0001238302 · Exe V-P & Pres, Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,230 Underlying: Common Stock · 8,770 shares Expires 2015-04-24 F14 · derivative.exercise_price: The option price for the grant expiring 4/24/15 will convert from $20.70 to $22.69. F7 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F6 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.